Real-time enrollment status for this pancreatic cancer clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 4:44 PM UTC
| NCT Number | NCT07491445 |
| Recruiting Status | Recruiting |
| Condition | Pancreatic Cancer |
| Phase | PHASE3 |
| Target Enrollment | 900 participants |
| Active Locations | 15 sites in the US |
| Sponsor | Revolution Medicines, Inc. |
| Last Updated on CT.gov | August 27, 2026 (16 hours ago) |
As of August 27, 2026: Clinical trial NCT07491445 is currently recruiting participants. This phase3 study for pancreatic cancer is actively seeking new participants at 15 locations across the United States. The study is sponsored by Revolution Medicines, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07491445 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07491445 was last updated 16 hours ago (August 27, 2026). HelloStudys verifies this status automatically.